Novabay Pharmaceuticals Inc
ASE:NBY
| Market Cap (Intraday) | 3.46M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 21.25 |
| 10-Day MA | $1.64 |
| 50-Day MA | $2.03 |
| 200-Day MA | $4.44 |
Novabay Pharmaceuticals Inc Stock, ASE:NBY
2000 Powell Street, Suite 1150, Emeryville, California 94608-1866
United States of America
Phone: +1.510.899.8800
Number of Employees: 31
Description
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.